Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INTIZOL VAGINAL 1.000 MG OVULOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/INTIZOL VAGINAL 1.000 MG OVULOS

Approved

STANDARD

INTIZOL VAGINAL 1.000 MG OVULOS

Seid S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 5, 2024
Approval ID: c19586431f2c62b5
Company: Seid S.A.
Type: Standard

Approval Details

Approval Id: c19586431f2c62b5
Drug Cima Aemps Name: INTIZOL VAGINAL 1.000 MG OVULOS
Register Number: 89284
Holder Company Name: Seid S.A.
Marketing Company Name: Seid S.A.
Authorization Date: 2024-02-05
Dosage Form: ÓVULO
Dose: 1.000 mg
Route Of Administration: VÍA VAGINAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Seid S.A.

Active Ingredients

METRONIDAZOL

1.000 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 5, 2024

Approval ID

c19586431f2c62b5

Type

Standard

Back to CIMA-AEMPS Approvals